Inflammatory biomarkers as predictors of complications after endovascular aneurysm repair in patients with abdominal aortic aneurysm: a focused narrative review
4 affiliations
- 1Department of Vascular Surgery and Transplantation, Medical University of Bialystok, Bialystok, Poland
- 2Department of Cardiology, Medical University of Bialystok, Bialystok, Poland
- 3Department of Intensive Cardiac Care, Medical University of Bialystok, Bialystok, Poland
- 4Department of Angiology, Vascular Surgery and Endovascular Surgery, Autonomous University of Barcelona, Barcelona, Spain
Abstract
Endovascular aneurysm repair (EVAR) reduces early morbidity and mortality in anatomically suitable patients with infrarenal abdominal aortic aneurysm, but long-term durability is limited by endoleaks, adverse aneurysm sac remodeling, and the need for reinterventions. This focused narrative review examines whether inflammatory biomarkers can help predict these complications. The evidence supports two biologically related but clinically distinct settings. First, post-implantation syndrome (PIS) is an early sterile inflammatory response. Higher preoperative white blood cell (WBC) count, C-reactive protein (CRP), and systemic inflammatory response index (SIRI), along with greater new-onset thrombus, have been associated with its occurrence. Postoperative CRP, interleukin-6 (IL-6), and leukocyte changes reflect its intensity. Second, persistent type II endoleak and adverse sac behavior have been linked to systemic inflammatory disease, neutrophil-to-lymphocyte ratio (NLR), cytokines including interleukin-1, interleukin-8, and monocyte chemoattractant protein-1, and dynamic matrix metalloproteinase (MMP) profiles. Serial CRP changes and higher preoperative NLR and platelet-to-lymphocyte ratio (PLR) have also been associated with sac expansion or failure to regress. However, acute PIS does not consistently predict late endoleak or sac expansion, and most biomarker studies are small, single-center, and heterogeneous. Biomarkers may therefore complement, but cannot replace, imaging surveillance. Standardized prospective studies are needed to validate temporal biomarker panels and determine whether they improve clinical decision-making.
Related
- Inflammatory Biomarkers as Predictors of In‐Hospital Mortality in Critically Ill COVID‐19 Patients: A Retrospective Cohort Study
- Hybrid approach with thoracic endovascular treatment and abdominal aortic replacement for acute type B aortic dissection complicated by ruptured abdominal aortic aneurysm
- Fenestrated-branched endovascular repair of a complex abdominal aortic aneurysm in a patient with a pelvic kidney and left ventricular assist device
- Fenestrated-branched endovascular repair of a complex abdominal aortic aneurysm in a patient with a pelvic kidney and left ventricular assist device
- Predictors of Clinically Driven Target Lesion Revascularization After Endovascular Treatment of Femoropopliteal Chronic Total Occlusions
BibTeX
@article{kuklinski2026inflammatory,
title = {{Inflammatory biomarkers as predictors of complications after endovascular aneurysm repair in patients with abdominal aortic aneurysm: a focused narrative review}},
author = {Franciszek M. Kukliński and Arkadiusz Woźniak and Teresa Fernandez Moreno and Agnieszka Tycińska and Sergi Bellmunt Montoya and Jerzy Głowiński},
journal = {Cardiology Journal},
year = {2026},
month = nov,
doi = {10.5603/cj.114481},
url = {https://doi.org/10.5603/cj.114481},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - Inflammatory biomarkers as predictors of complications after endovascular aneurysm repair in patients with abdominal aortic aneurysm: a focused narrative review
AU - Franciszek M. Kukliński
AU - Arkadiusz Woźniak
AU - Teresa Fernandez Moreno
AU - Agnieszka Tycińska
AU - Sergi Bellmunt Montoya
AU - Jerzy Głowiński
PY - 2026
DA - 2026/11/10
JO - Cardiology Journal
DO - 10.5603/cj.114481
UR - https://doi.org/10.5603/cj.114481
AB - Endovascular aneurysm repair (EVAR) reduces early morbidity and mortality in anatomically suitable patients with infrarenal abdominal aortic aneurysm, but long-term durability is limited by endoleaks, adverse aneurysm sac remodeling, and the need for reinterventions. This focused narrative review examines whether inflammatory biomarkers can help predict these complications. The evidence supports two biologically related but clinically distinct settings. First, post-implantation syndrome (PIS) is an early sterile inflammatory response. Higher preoperative white blood cell (WBC) count, C-reactive protein (CRP), and systemic inflammatory response index (SIRI), along with greater new-onset thrombus, have been associated with its occurrence. Postoperative CRP, interleukin-6 (IL-6), and leukocyte changes reflect its intensity. Second, persistent type II endoleak and adverse sac behavior have been linked to systemic inflammatory disease, neutrophil-to-lymphocyte ratio (NLR), cytokines including interleukin-1, interleukin-8, and monocyte chemoattractant protein-1, and dynamic matrix metalloproteinase (MMP) profiles. Serial CRP changes and higher preoperative NLR and platelet-to-lymphocyte ratio (PLR) have also been associated with sac expansion or failure to regress. However, acute PIS does not consistently predict late endoleak or sac expansion, and most biomarker studies are small, single-center, and heterogeneous. Biomarkers may therefore complement, but cannot replace, imaging surveillance. Standardized prospective studies are needed to validate temporal biomarker panels and determine whether they improve clinical decision-making.
SN - 1897-5593
SN - 1898-018X
ER -